Mylan is dealing with more negative reports on executive pay. The company, which has come under fire for the price of the life-saving EpiPen, has the second-highest executive compensation package in the industry, according to the Wall Street Journal. Over the past five years, Mylan has paid its top five managers a total of nearly $300 million.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
